SCHEMBL290602

SCHEMBL290602

O=C(O)CC(O)C(=O)OC(CC(=O)O)(CC(=O)O)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.41
SLC22A6 Q4U2R8 1/20 0.34
CPT2 P23786 1/20 0.34
ACLY P53396 1/20 0.34
TDP1 Q9NUW8 1/20 0.33
ALDH1A1 P00352 1/20 0.32
CYP2D6 P10635 1/20 0.31
TSHR P16473 1/20 0.31
CYP2C19 P33261 1/20 0.31
HIF1A Q16665 1/20 0.31
GABRR1 P24046 2/20 0.30
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11284194 0.98 SMN1; SMN2 (0.40) SMN1; SMN2SLC22A6CPT2ACLYTDP1
Lactic Acid SCHEMBL7758364 0.92 SMN1; SMN2 (0.39) SMN1; SMN2CPT2ACLYTDP1CYP2D6
SCHEMBL290603 0.89 CPT2 (0.32) SMN1; SMN2CPT2ACLYALDH1A1
SCHEMBL28778140 0.87 CPT2 (0.32) CPT2ACLY
SCHEMBL247923 0.87 CPT2 (0.32) CPT2ACLY
SCHEMBL28954899 0.87 CPT2 (0.32) CPT2ACLY
SCHEMBL3955192 0.87 CPT2 (0.32) CPT2ACLY
SCHEMBL3647978 0.87 CPT2 (0.32) CPT2ACLY
SCHEMBL28954895 0.87 CPT2 (0.32) CPT2ACLY
SCHEMBL28307091 0.87 CPT2 (0.32) CPT2ACLY

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 278 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4030921-B1 WHEY-BASED NUTRITIONAL COMPOSITIONS FORTIFIED WITH CALCIUM NESTLE SA (CH) 2024-02-21 EP claimed
CN-115710174-A Preparation method of high-density citric acid malic acid chelate 南通励成生物工程有限公司 2023-02-24 CN claimed
US-11534458-B2 Phosphorus-sparing nutritional composition ALBION LABORATORIES, INC. (US) 2022-12-27 US claimed
CN-114946852-A Citric acid and malic acid powder disinfectant and preparation method thereof 山东菏泽三仪生物工程有限公司 2022-08-30 CN claimed
US-20210137975-A1 PHOSPHORUS-SPARING NUTRITIONAL COMPOSITION JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT 2021-05-13 US claimed
CN-111713624-A Solid beverage and preparation method and application thereof 同方药业集团有限公司 2020-09-29 CN claimed
CN-110787132-A Veterinary disinfectant citric acid and malic acid powder and preparation method thereof 河南牧翔动物药业有限公司 2020-02-14 CN claimed
EP-1755578-B2 CHEWABLE, SUCKABLE AND SWALLOWABLE TABLET CONTAINING A CALCIUM-CONTAINING COMPOUND AS AN ACTIVE SUBSTANCE TAKEDA AS (NO) 2018-11-28 EP claimed
CN-108634242-A Green pepper fiber crops jujube pantry pickles and production method 中玺(天津)枣业技术工程中心 2018-10-12 CN claimed
CN-108618033-A Spicy jujube is gone with rice or bread pickles and production method 中玺(天津)枣业技术工程中心 2018-10-09 CN claimed
WO-2001077044-A1 AQUEOUS MINERAL COMPOSITIONS AND METHODS FOR THEIR USE YAMASHITA THOMAS T (US) 2001-10-18 WO claimed
EP-0697877-B1 PSYLLIUM DRINK MIX COMPOSITIONS PROCTER & GAMBLE (US) 2001-09-19 EP claimed
EP-1104998-A1 COMPOSITION Advanced Nutricional Foods Pty. Limited (AU) 2001-06-13 EP claimed
WO-2000045650-A1 CALCIUM SUPPLEMENTED FOOD PRODUCTS AND NOVEL CALCIUM-CONTAINING INGREDIENT NUTRAHEALTH LTD. (UK) (GB) 2000-08-10 WO claimed
WO-2000010402-A1 COMPOSITION ADVANCED NUTRITIONAL FOODS PTY. LIMITED (AU) 2000-03-02 WO claimed
EP-0697821-B1 CHOLESTEROL LOWERING DRINK MIX COMPOSITIONS PROCTER & GAMBLE (US) 1998-11-18 EP claimed
EP-0542912-A1 CALCIUM AND TRACE MINERAL SUPPLEMENTS. PROCTER & GAMBLE (US) 1993-05-26 EP claimed
US-5151274-A Calcium citrate malate for bone disorders THE PROCTER & GAMBLE COMPANY (US) 1992-09-29 US claimed
WO-1992002235-A1 CALCIUM AND TRACE MINERAL SUPPLEMENTS THE PROCTER & GAMBLE COMPANY (US) 1992-02-20 WO claimed
US-4948799-A ANTIPSYCHOTIC DRUGS SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1990-08-14 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11534458-B2 Phosphorus-sparing nutritional composition PHPT1, PPA1, PTH1R SMN1; SMN2 1232/4885SLC22A6 662/4885CPT2 813/4885
US-20210137975-A1 PHOSPHORUS-SPARING NUTRITIONAL COMPOSITION PHPT1, PPA1, PTH1R SMN1; SMN2 1232/4885SLC22A6 662/4885CPT2 813/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.